Abstract:
A driving circuit for an LCD system is provided. The LCD system includes a common electrode, a display electrode, and a capacitor. An AC voltage output terminal of the driving circuit is coupled to the common electrode via the capacitor. The display electrode and a charging/discharging unit in the driving circuit are respectively coupled to the AC voltage output terminal through a switch. According to requirements to change the electrical polarity of the common electrode, a control unit in the driving circuit turns on/off the two switches respectively so as to charge or discharge the AC voltage output terminal.
Abstract:
A cultured pluripotent animal cell that is CD13+, CD90+, and CD117−. Also disclosed are methods for making the cell and methods of treating a brain tissue damage and increasing the expression level of a neuraltrophic factor in a subject.
Abstract:
A frame rate control (FRC) method is provided for driving a number of pixels according to a number of pixels data. The pixels include a number of first color sub-pixels. In this method, the dithering process is performed to the pixels data in two frames according to two basic matrixes respectively. In one of the two frames, the numbers of the first color sub-pixels, driven by the positive pixel voltages and the negative pixel voltages and to which the dithering process has been performed, are the same in substantiality. Further, in the other of the two frames, the numbers of the first color sub-pixels, driven by the positive pixel voltages and the negative pixel voltages and to which the dithering process has been performed, are also the same in substantiality.
Abstract:
A method for treating a cerebrovascular disease with erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) jointly by first identifying a subject in need of the treatment and then administering to the subject an effective combined amount of EPO and G-CSF. Also disclosed is a method for increasing in a subject expression of EPO with G-CSF.
Abstract:
Compositions for treatment of spinal muscular atrophy (SMA) and methods for use thereof to treat SMA and other conditions of SMN-deficiency; novel drug development targets for SMA therapies, and methods of use thereof to screen for candidate therapeutic and diagnostic agents.
Abstract:
A method of treating brain tissue damage, including administering to a subject in need thereof an effective amount of secretoneurin. Disclosed are methods of promoting angiogenesis or neurogenesis in the brain of subject. Also disclosed are a method of homing of stem cells to the brain of a subject and a method of protecting a neuronal cell from cell death.
Abstract:
The invention provides methods and compositions useful in pearl oyster cultivation. Polynucleotide and polypeptides relating to the nacre gene of Pinctada margaritifera are provided. Antibodies related to these polypeptides, and compositions comprising polynucleotides, polypeptides and/or antibodies of the invention are also provided. The invention provides methods of using these polynucleotides, polypeptides and antibodies, including methods related to pearl oyster cultivation. Arrays comprising polynucleotides, polypeptides and/or antibodies of the invention are also provided.
Abstract:
Methods of treating brain tissue damage, increasing the expression level of a neuraltrophic factor in a cell, and enhancing angiogenesis in a tissue.